Long-term maintenance therapy with digoxin is the best option in the following category of CHF patients: A. Hypertensive patients B. Patients with hypertrophic cardiomyopathy C. Patients with associated atrial fibrillation D. Patients having cardiac valvular defects

Long-term maintenance therapy with digoxin is the
best option in the following category of CHF patients:
A. Hypertensive patients
B. Patients with hypertrophic cardiomyopathy
C. Patients with associated atrial fibrillation
D. Patients having cardiac valvular defects
by

1 Answer

Answer :

C. Patients with associated atrial fibrillation
by

Related questions

Digoxin given for cardiac failure is extremely valuable in patients of (a) Thyrotoxicosis (b) Beriberi (c) Cor pulmonale (d) Atrial fibrillation

Description : Digoxin given for cardiac failure is extremely valuable in patients of (a) Thyrotoxicosis (b) Beriberi (c) Cor pulmonale (d) Atrial fibrillation

Last Answer : Ans: D

The most effective drug for prevention of stroke in atrial fibrillation patients is: A. Aspirin B. Warfarin C. Low dose subcutaneous heparin D. Digoxin

Description : The most effective drug for prevention of stroke in atrial fibrillation patients is: A. Aspirin B. Warfarin C. Low dose subcutaneous heparin D. Digoxin

Last Answer : B. Warfarin

Digoxin affords the following benefit/benefits in CHF: A. Restores cardiac compensation and relieves symptoms B. Reverses the pathological changes of CHF C. Prolongs survival of CHF patients D. Both ‘A’ and ‘B’ are correc

Description : Digoxin affords the following benefit/benefits in CHF: A. Restores cardiac compensation and relieves symptoms B. Reverses the pathological changes of CHF C. Prolongs survival of CHF patients D. Both ‘A’ and ‘B’ are correc

Last Answer : A. Restores cardiac compensation and relieves symptoms

Digoxin produces the following effect(s) in atrial flutter: A. Reduces ventricular rate B. Prevents shift of A-V block to a lower grade C. Converts atrial flutter to atrial fibrillation D. All of the above

Description : Digoxin produces the following effect(s) in atrial flutter: A. Reduces ventricular rate B. Prevents shift of A-V block to a lower grade C. Converts atrial flutter to atrial fibrillation D. All of the above

Last Answer : D. All of the above

What is the usual response to digoxin in a patient of atrial fibrillation: A. Restoration of normal sinus rhythm B. Conversion of atrial fibrillation to atrial flutter C. Increase in atrial fibrillation frequency, but decrease in ventricular rate D. Decrease in atrial fibrillation frequency, but increase in ventricular rate

Description : What is the usual response to digoxin in a patient of atrial fibrillation: A. Restoration of normal sinus rhythm B. Conversion of atrial fibrillation to atrial flutter C. Increase in ... decrease in ventricular rate D. Decrease in atrial fibrillation frequency, but increase in ventricular rate

Last Answer : C. Increase in atrial fibrillation frequency, but decrease in ventricular rate

Benzathine penicillin injected once every 4 weeks for 5 years or more is the drug of choice for: A. Agranulocytosis patients B. Prophylaxis of bacterial endocarditis in patients with valvular defects C. Prophylaxis of rheumatic fever D. Treatment of anthrax

Description : Benzathine penicillin injected once every 4 weeks for 5 years or more is the drug of choice for: A. Agranulocytosis patients B. Prophylaxis of bacterial endocarditis in patients with valvular defects C. Prophylaxis of rheumatic fever D. Treatment of anthrax

Last Answer : C. Prophylaxis of rheumatic fever

Choose the correct statement about use of βadrenergic blockers in CHF: A. All β blockers are equally effective in CHF B. They are used as alternative to conventional therapy with ACE inhibitors ± digitalis/ diuretic C. They are most useful in mild to moderate cases with systolic dysfunction due to dilated cardiomyopathy D. They are indicated only in asymptomatic left ventricular dysfunction

Description : Choose the correct statement about use of βadrenergic blockers in CHF: A. All β blockers are equally effective in CHF B. They are used as alternative to conventional therapy with ... dysfunction due to dilated cardiomyopathy D. They are indicated only in asymptomatic left ventricular dysfunction

Last Answer : C. They are most useful in mild to moderate cases with systolic dysfunction due to dilated cardiomyopathy

ignocaine is effective in the following cardiac arrhythmia(s): A. Atrial fibrillation B. Paroxysmal supraventricular tachycardia C. Digitalis induced ventricular extrasystoles D. All of the above

Description : ignocaine is effective in the following cardiac arrhythmia(s): A. Atrial fibrillation B. Paroxysmal supraventricular tachycardia C. Digitalis induced ventricular extrasystoles D. All of the above

Last Answer : C. Digitalis induced ventricular extrasystoles

Digoxin is contraindicated in: A. Angina pectoris patients B. Ventricular tachycardia C. Hypertensive patients D. Complete heart-block

Description : Digoxin is contraindicated in: A. Angina pectoris patients B. Ventricular tachycardia C. Hypertensive patients D. Complete heart-block

Last Answer : B. Ventricular tachycardia

Milrinone is best used: A. In a patient of mild CHF B. As an additional drug alongwith conventional therapy to tide over crisis in refractory CHF C. For long-term maintenance therapy of CHF D. To suppress digitalis induced arrhythmias

Description : Milrinone is best used: A. In a patient of mild CHF B. As an additional drug alongwith conventional therapy to tide over crisis in refractory CHF C. For long-term maintenance therapy of CHF D. To suppress digitalis induced arrhythmias

Last Answer : B. As an additional drug alongwith conventional therapy to tide over crisis in refractory CHF

Select the drug that can help restore cardiac performance as well as prolong survival in CHF patients: A. Spironolactone B. Furosemide C. Dobutamine D. Metoprolol

Description : Select the drug that can help restore cardiac performance as well as prolong survival in CHF patients: A. Spironolactone B. Furosemide C. Dobutamine D. Metoprolol

Last Answer : D. Metoprolol

The following is true of β-adrenergic blocker therapy in CHF: A. They are added to conventional therapy after cardiac compensation is restored B. They are indicated only in severe (NYHA class IV) heart failure C. They are to be used only at low doses D. All of the above

Description : The following is true of β-adrenergic blocker therapy in CHF: A. They are added to conventional therapy after cardiac compensation is restored B. They are indicated only in severe (NYHA class IV) heart failure C. They are to be used only at low doses D. All of the above

Last Answer : A. They are added to conventional therapy after cardiac compensation is restored

Because of proven beneficial effects on “cardiac remodeling”, these agents are now indicated as first line therapy in CHF patients. Which of the following is representative of this group of drugs? (a) Hydrochlorothiazide (b) Enalapril (c) Furosemide (d) Carvedilol (e) Bumetanide

Description : Because of proven beneficial effects on “cardiac remodeling”, these agents are now indicated as first line therapy in CHF patients. Which of the following is representative of this group of drugs? (a) Hydrochlorothiazide (b) Enalapril (c) Furosemide (d) Carvedilol (e) Bumetanide

Last Answer : Ans: B

Benzathine penicillin injected once every 4 weeks for 5 years or more is the drug of choice for (a) Agranulocytosis patients (b) Prophylaxis of bacterial endocarditis in patients with valvular defects (c) Prophylaxis of rheumatic fever (d) Treatment of anthrax

Description : Benzathine penicillin injected once every 4 weeks for 5 years or more is the drug of choice for (a) Agranulocytosis patients (b) Prophylaxis of bacterial endocarditis in patients with valvular defects (c) Prophylaxis of rheumatic fever (d) Treatment of anthrax

Last Answer : Ans: C

Long term ACE inhibitor therapy may retard the progression of: A. Diabetic nephropathy B. Diabetic retinopathy C. Hypertensive nephropathy D. All of the above

Description : Long term ACE inhibitor therapy may retard the progression of: A. Diabetic nephropathy B. Diabetic retinopathy C. Hypertensive nephropathy D. All of the above

Last Answer : D. All of the above

Infusion of potassium chloride is indicated in digitalis toxicity when the manifestation(s) is/are: A. Vomiting, hyperapnoea and visual disturbance B. Pulsus bigeminus with heart rate 110/min in a patient on maintenance digoxin therapy C. Ventricular tachycardia in a child who has accidentally ingested 10 digoxin tablets D. 2:1 A-V block with occasional ventricular extrasystoles

Description : Infusion of potassium chloride is indicated in digitalis toxicity when the manifestation(s) is/are: A. Vomiting, hyperapnoea and visual disturbance B. Pulsus bigeminus with heart rate 110/min ... accidentally ingested 10 digoxin tablets D. 2:1 A-V block with occasional ventricular extrasystoles

Last Answer : B. Pulsus bigeminus with heart rate 110/min in a patient on maintenance digoxin therapy

How can I test for atrial fibrillation (a form of cardiac arrhythmia)?

Description : How can I test for atrial fibrillation (a form of cardiac arrhythmia)?

Last Answer : A doctor can detect an irregular heartbeat during a physical exam by taking your pulse, listening to your heartbeat or by performing diagnostic tests.

Quinidine is now used primarily for: A. Conversion of atrial fibrillation to sinus rhythm B. Control of ventricular rate in atrial flutter C. Termination of ventricular tachycardia D. Prevention of recurrences of atrial fibrillation/ ventricular tachycardia

Description : Quinidine is now used primarily for: A. Conversion of atrial fibrillation to sinus rhythm B. Control of ventricular rate in atrial flutter C. Termination of ventricular tachycardia D. Prevention of recurrences of atrial fibrillation/ ventricular tachycardia

Last Answer : D. Prevention of recurrences of atrial fibrillation/ ventricular tachycardia

Quinidine can cause paradoxical tachycardia in a patient of: A. Sick sinus syndrome B. Atrial extrasystoles C. Atrial fibrillation D. Ventricular extrasystoles

Description : Quinidine can cause paradoxical tachycardia in a patient of: A. Sick sinus syndrome B. Atrial extrasystoles C. Atrial fibrillation D. Ventricular extrasystoles

Last Answer : C. Atrial fibrillation

The following action of digoxin is responsible for beneficial effect in auricular fibrillation: A. Increased myocardial contractility B. Suppression of SA node C. Depression of A-V conduction D. Enhanced Purkinje fibre automaticity

Description : The following action of digoxin is responsible for beneficial effect in auricular fibrillation: A. Increased myocardial contractility B. Suppression of SA node C. Depression of A-V conduction D. Enhanced Purkinje fibre automaticity

Last Answer : C. Depression of A-V conduction

Which of the following drugs can afford both haemodynamic improvement as well as disease modifying benefits in CHF: A. Furosemide B. Milrinone C. Losartan D. Digoxin

Description : Which of the following drugs can afford both haemodynamic improvement as well as disease modifying benefits in CHF: A. Furosemide B. Milrinone C. Losartan D. Digoxin

Last Answer : C. Losartan

The following drug can relieve symptoms of CHF but does not retard disease progression or prolong survival: A. Digoxin B. Carvedilol C. Spironolactone D. Ramipril

Description : The following drug can relieve symptoms of CHF but does not retard disease progression or prolong survival: A. Digoxin B. Carvedilol C. Spironolactone D. Ramipril

Last Answer : A. Digoxin

A patient of CHF was treated with furosemide and digoxin. He became symptom-free and is stable for the last 3 months with resting heart rate 68/min in sinus rhythm but left ventricular ejection fraction is low. Which of the following lines of action is warranted: A. Stop above medication and start an ACE inhibitor B. Continue all medication as before C. Continue the diuretic but stop digoxin D. Continue digoxin but stop the diuretic

Description : A patient of CHF was treated with furosemide and digoxin. He became symptom-free and is stable for the last 3 months with resting heart rate 68/min in sinus rhythm but left ventricular ... medication as before C. Continue the diuretic but stop digoxin D. Continue digoxin but stop the diuretic

Last Answer : A. Stop above medication and start an ACE inhibitor

The dose of digoxin in congestive heart failure is adjusted by monitoring: A. Electrocardiogram B. Heart rate and symptoms of CHF C. Blood pressure D. Plasma digoxin levels

Description : The dose of digoxin in congestive heart failure is adjusted by monitoring: A. Electrocardiogram B. Heart rate and symptoms of CHF C. Blood pressure D. Plasma digoxin levels

Last Answer : B. Heart rate and symptoms of CH

Newborn with 300 bpm , with normal BP , normal RR , what do you will do for newborn : (atrial flutter) imp.  Cardiac Cardiversion  Verpamil  Digoxin  Diltzam iv

Description : Newborn with 300 bpm , with normal BP , normal RR , what do you will do for newborn : (atrial flutter) imp.  Cardiac Cardiversion  Verpamil  Digoxin  Diltzam iv

Last Answer : Digoxin

Captopril produces greater fall in blood pressure in: A. Diuretic treated patients B. Patients having low plasma renin activity C. Sodium replete normotensive individuals D. Untreated CHF patient

Description : Captopril produces greater fall in blood pressure in: A. Diuretic treated patients B. Patients having low plasma renin activity C. Sodium replete normotensive individuals D. Untreated CHF patient

Last Answer : A. Diuretic treated patients

The following drug increases cardiac output in congestive heart failure without having any direct myocardial action: A. Captopril B. Digoxin C. Amrinone D. Dobutamine

Description : The following drug increases cardiac output in congestive heart failure without having any direct myocardial action: A. Captopril B. Digoxin C. Amrinone D. Dobutamine

Last Answer : A. Captopril

Anti-HIV drug therapy is recommended in the following category of HIV exposed subjects: A. HIV positive symptomatic patients with opportunistic infections B. HIV positive asymptomatic subjects with CD4 cell count more than 400/μl C. HIV positive asymptomatic subjects with CD4 cell count less than 200/μl D. Both 'A' and 'C

Description : Anti-HIV drug therapy is recommended in the following category of HIV exposed subjects: A. HIV positive symptomatic patients with opportunistic infections B. HIV positive asymptomatic subjects with CD4 cell count ... asymptomatic subjects with CD4 cell count less than 200/μl D. Both 'A' and 'C

Last Answer : C. HIV positive asymptomatic subjects with CD4 cell count less than 200/μl

Bacteriostatic drugs are unlikely to effect cure of bacterial infection in the following category of patients except: A. Diabetic patients B. Patients with allergic disorders C. Patients on corticosteroid therapy D. Subacute bacterial endocarditis patient

Description : Bacteriostatic drugs are unlikely to effect cure of bacterial infection in the following category of patients except: A. Diabetic patients B. Patients with allergic disorders C. Patients on corticosteroid therapy D. Subacute bacterial endocarditis patient

Last Answer : B. Patients with allergic disorders

Insulin therapy is required for the following category/ categories of type 2 diabetes mellitus patients: A. Patients with ketoacidosis B. Patients undergoing surgery C. Pregnant diabetic D. All of the above

Description : Insulin therapy is required for the following category/ categories of type 2 diabetes mellitus patients: A. Patients with ketoacidosis B. Patients undergoing surgery C. Pregnant diabetic D. All of the above

Last Answer : D. All of the above

Insulin therapy is required for the following category/ categories of type 2 diabetes mellitus patients: A. Patients with ketoacidosis B. Patients undergoing surgery C. Pregnant diabetic D. All of the above

Description : Insulin therapy is required for the following category/ categories of type 2 diabetes mellitus patients: A. Patients with ketoacidosis B. Patients undergoing surgery C. Pregnant diabetic D. All of the above

Last Answer : D. All of the above

Raised plasma aldosterone level in CHF contributes to disease progression by exerting the following effects except: A. Fibrotic remodeling of myocardium B. Hyperkalemia and hypermagnesemia C. Increasing cardiac preload by Na+ and water retention D. Enhancing cardiotoxicity of sympathetic overactivity

Description : Raised plasma aldosterone level in CHF contributes to disease progression by exerting the following effects except: A. Fibrotic remodeling of myocardium B. Hyperkalemia and hypermagnesemia C. ... cardiac preload by Na+ and water retention D. Enhancing cardiotoxicity of sympathetic overactivity

Last Answer : B. Hyperkalemia and hypermagnesemia

Beneficial effects of β-adrenoceptor blockers in CHF include the following except: A. Antagonism of ventricular wall stress enhancing action of sympathetic overactivity B. Antagonism of vasoconstriction due to sympathetic overactivity C. Prevention of pathological remodeling of ventricular myocardium D. Prevention of dangerous cardiac arrhythmias

Description : Beneficial effects of β-adrenoceptor blockers in CHF include the following except: A. Antagonism of ventricular wall stress enhancing action of sympathetic overactivity B. Antagonism ... Prevention of pathological remodeling of ventricular myocardium D. Prevention of dangerous cardiac arrhythmias

Last Answer : B. Antagonism of vasoconstriction due to sympathetic overactivity

Which vasodilator is most suitable for a patient of CHF who is symptomatic even at rest and has a central venous pressure of 25 mm Hg and cardiac index 1.8 L/min/m2 : A. Glyceryl trinitrate B. Enalapril C. Hydralazine D. Nifedipine

Description : Which vasodilator is most suitable for a patient of CHF who is symptomatic even at rest and has a central venous pressure of 25 mm Hg and cardiac index 1.8 L/min/m2 : A. Glyceryl trinitrate B. Enalapril C. Hydralazine D. Nifedipine

Last Answer : B. Enalapril

The basis for use of β-adrenergic blockers in congestive heart failure (CHF) is: A. They exert positive inotropic effect in CHF B. They counteract deleterious effect of sympathetic overactivity on the myocardium C. They exert antiischaemic effect on the heart D. They prevent cardiac arrhythmias

Description : The basis for use of β-adrenergic blockers in congestive heart failure (CHF) is: A. They exert positive inotropic effect in CHF B. They counteract deleterious effect of sympathetic overactivity on the myocardium C. They exert antiischaemic effect on the heart D. They prevent cardiac arrhythmias

Last Answer : B. They counteract deleterious effect of sympathetic overactivity on the myocardium

The basis for use of β -adrenergic blockers in congestive heart failure (CHF) is: A. They exert positive inotropic effect in CHF B. They counteract deleterious effect of sympathetic overactivity on the myocardium C. They exert antiischaemic effect on the heart D. They prevent cardiac arrhythmias

Description : The basis for use of β -adrenergic blockers in congestive heart failure (CHF) is: A. They exert positive inotropic effect in CHF B. They counteract deleterious effect of sympathetic overactivity on the myocardium C. They exert antiischaemic effect on the heart D. They prevent cardiac arrhythmias

Last Answer : B. They counteract deleterious effect of sympathetic overactivity on the myocardium

Hypertrophic cardiomyopathy?

Description : Hypertrophic cardiomyopathy?

Last Answer : DefinitionHypertrophic cardiomyopathy (HCM) is a condition in which the heart muscle becomes thick. The thickening makes it harder for blood to leave the heart, forcing the heart to work ... heart muscle growth.Younger people are likely to have a more severe form of hypertrophic cardiomyopathy

What is hypertrophic cardiomyopathy and how can it be avoided?

Description : What is hypertrophic cardiomyopathy and how can it be avoided?

Last Answer : It is a condition of the heart muscles thickening and is often genetic. It can be treated with exercise and blood thinners are suggested by the doctor to avoid blood clots.

Propranolol is useful in all of the following except (a) Angina (b) Familial tremor (c) Hypertension (d) Idiopathic hypertrophic subaortic cardiomyopathy (e) Partial atrioverntricular heart block

Description : Propranolol is useful in all of the following except (a) Angina (b) Familial tremor (c) Hypertension (d) Idiopathic hypertrophic subaortic cardiomyopathy (e) Partial atrioverntricular heart block

Last Answer : Ans: E

In which type of cardiomyopathy does the heart muscle actually increase in size and mass weight, especially along the septum? a) Hypertrophic Because of the structural changes, hypertrophic cardiomyopathy had also been called idiopathic hypertrophic subaortic stenosis (IHSS) or asymmetric septal hypertrophy (ASH).

Description : In which type of cardiomyopathy does the heart muscle actually increase in size and mass weight, especially along the septum? a) Hypertrophic Because of the structural changes, hypertrophic ... of the right ventricle is progressively infiltrated and replaced by fibrous scar and adipose tissue

Last Answer : a) Hypertrophic Because of the structural changes, hypertrophic cardiomyopathy had also been called idiopathic hypertrophic subaortic stenosis (IHSS) or asymmetric septal hypertrophy (ASH).

yo presented by hx of syncope when he do excurses and there was hix of same complain when he on rest . and there is chest pain on ex. There was ejection systolic murmur 2-4 degree most side is lower lf sternum not radiating to other site increase when he lying down and there is non specific s and t changing and there is lf atrium enlargement Aortic stenosis p.s hypertrophic cardiomyopathy constrictive cardiomyopathy

Description : yo presented by hx of syncope when he do excurses and there was hix of same complain when he on rest . and there is chest pain on ex. There was ejection systolic murmur ... t changing and there is lf atrium enlargement Aortic stenosis p.s hypertrophic cardiomyopathy constrictive cardiomyopathy

Last Answer : Aortic stenosis

β-adrenergic blockers are indicated in the following conditions except: A. Hypertrophic cardiomyopathy B. Congestive heart failure C. Vasospastic angina pectoris D. Dissecting aortic aneurysm

Description : β-adrenergic blockers are indicated in the following conditions except: A. Hypertrophic cardiomyopathy B. Congestive heart failure C. Vasospastic angina pectoris D. Dissecting aortic aneurysm

Last Answer : C. Vasospastic angina pectoris

β -adrenergic blockers are indicated in the following conditions except: A. Hypertrophic cardiomyopathy B. Congestive heart failure C. Vasospastic angina pectoris D. Dissecting aortic aneurysm

Description : β -adrenergic blockers are indicated in the following conditions except: A. Hypertrophic cardiomyopathy B. Congestive heart failure C. Vasospastic angina pectoris D. Dissecting aortic aneurysm

Last Answer : C. Vasospastic angina pectoris

Beneficial effect/effects of diuretics in CHF patients include the following: A. Symptomatic relief B. Regression of pathological changes C. Prolongation of life expectancy D. Both ‘A’ and ‘C’

Description : Beneficial effect/effects of diuretics in CHF patients include the following: A. Symptomatic relief B. Regression of pathological changes C. Prolongation of life expectancy D. Both ‘A’ and ‘C’

Last Answer : A. Symptomatic relief

Lignocaine is the preferred antiarrhythmic for emergency control of cardiac arrhythmias following acute myocardial infarction because: A. It has a rapidly developing and titratable antiarrhythmic action B. It causes little myocardial depression and hypotension C. It has broad spectrum antiarrhythmic efficacy in atrial as well as ventricular arrhythmias D. Both ‘A’ and ‘B’ are correct

Description : Lignocaine is the preferred antiarrhythmic for emergency control of cardiac arrhythmias following acute myocardial infarction because: A. It has a rapidly developing and titratable antiarrhythmic action B. It causes ... atrial as well as ventricular arrhythmias D. Both A' and B' are correct

Last Answer : D. Both ‘A’ and ‘B’ are correct

Angiotensin converting enzyme inhibitors reduce the following haemodynamic parameters in congestive heart failure except: A. Systemic vascular resistance B. Right atrial pressure C. Cardiac output D. Heart rate × pressure product

Description : Angiotensin converting enzyme inhibitors reduce the following haemodynamic parameters in congestive heart failure except: A. Systemic vascular resistance B. Right atrial pressure C. Cardiac output D. Heart rate × pressure product

Last Answer : C. Cardiac output

Among all cardiac glycosides, digoxin is the most commonly used, because: A. It is the most potent and fastest acting glycoside B. It has the highest and most consistent oral bioavailability C. It is the longest acting and the safest glycoside D. It has intermediate plasma half life so that dose adjustments are possible every 2-3 days and toxicity abates rather rapidly after discontinuatio

Description : Among all cardiac glycosides, digoxin is the most commonly used, because: A. It is the most potent and fastest acting glycoside B. It has the highest and most consistent oral ... so that dose adjustments are possible every 2-3 days and toxicity abates rather rapidly after discontinuatio

Last Answer : D. It has intermediate plasma half life so that dose adjustments are possible every 2-3 days and toxicity abates rather rapidly after discontinuatio

n a failing heart therapeutic dose of digoxin has no effect on the following parameter: A. Cardiac output B. Heart rate C. Tone of ventricular fibres D. Cardiac vagal tone

Description : n a failing heart therapeutic dose of digoxin has no effect on the following parameter: A. Cardiac output B. Heart rate C. Tone of ventricular fibres D. Cardiac vagal tone

Last Answer : C. Tone of ventricular fibres

The following apply to use of spironolactone in CHF except: A. It is indicated only in NYHA class III/IV cases as additional drug to conventional therapy B. It affords prognostic benefit in severe heart failure over and above that afforded by ACE inhibitors C. It helps overcome refractoriness to diuretics D. It affords rapid symptomatic relief

Description : The following apply to use of spironolactone in CHF except: A. It is indicated only in NYHA class III/IV cases as additional drug to conventional therapy B. It affords prognostic benefit in ... by ACE inhibitors C. It helps overcome refractoriness to diuretics D. It affords rapid symptomatic relief

Last Answer : D. It affords rapid symptomatic relief

Choose the correct statement about aspirin: A. In an afebrile patient acute overdose of aspirin produces hypothermia B. Aspirin suppresses flushing attending large dose of nicotinic acid C. Aspirin therapy prevents granulomatous lesions and cardiac complications of acute rheumatic fever D. Long term aspirin therapy increases the risk of developing colon cancer

Description : Choose the correct statement about aspirin: A. In an afebrile patient acute overdose of aspirin produces hypothermia B. Aspirin suppresses flushing attending large dose of nicotinic acid C. Aspirin ... acute rheumatic fever D. Long term aspirin therapy increases the risk of developing colon cancer

Last Answer : B. Aspirin suppresses flushing attending large dose of nicotinic acid